Citadel Advisors’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-4,902
| Closed | -$686K | – | 5353 |
|
|
2018
Q4 | $686K | Buy |
4,902
+2,240
| +84% | +$313K | ﹤0.01% | 3062 |
|
|
2018
Q3 | $455K | Sell |
2,662
-18,721
| -88% | -$3.2M | ﹤0.01% | 3216 |
|
|
2018
Q2 | $3.71M | Buy |
21,383
+14,511
| +211% | +$2.52M | ﹤0.01% | 1644 |
|
|
2018
Q1 | $793K | Buy |
+6,872
| New | +$793K | ﹤0.01% | 2622 |
|
|
2017
Q4 | – | Sell |
-35,477
| Closed | -$3.27M | – | 4492 |
|
|
2017
Q3 | $3.27M | Buy |
35,477
+9,226
| +35% | +$850K | ﹤0.01% | 1526 |
|
|
2017
Q2 | $2.11M | Buy |
26,251
+994
| +4% | +$79.7K | ﹤0.01% | 1669 |
|
|
2017
Q1 | $1.06M | Buy |
+25,257
| New | +$1.06M | ﹤0.01% | 2090 |
|
|
2016
Q1 | – | Sell |
-25,501
| Closed | -$726K | – | 4266 |
|
|
2015
Q4 | $726K | Buy |
+25,501
| New | +$726K | ﹤0.01% | 2176 |
|